Cargando…
Development of a high-throughput screen to identify small molecule enhancers of sarcospan for the treatment of Duchenne muscular dystrophy
BACKGROUND: Duchenne muscular dystrophy (DMD) is caused by loss of sarcolemma connection to the extracellular matrix. Transgenic overexpression of the transmembrane protein sarcospan (SSPN) in the DMD mdx mouse model significantly reduces disease pathology by restoring membrane adhesion. Identifying...
Autores principales: | Shu, Cynthia, Kaxon-Rupp, Ariana N., Collado, Judd R., Damoiseaux, Robert, Crosbie, Rachelle H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907331/ https://www.ncbi.nlm.nih.gov/pubmed/31831063 http://dx.doi.org/10.1186/s13395-019-0218-x |
Ejemplares similares
-
High-throughput screening identifies modulators of sarcospan that stabilize muscle cells and exhibit activity in the mouse model of Duchenne muscular dystrophy
por: Shu, Cynthia, et al.
Publicado: (2020) -
Sarcospan: a small protein with large potential for Duchenne muscular dystrophy
por: Marshall, Jamie L, et al.
Publicado: (2013) -
Sarcospan Regulates Cardiac Isoproterenol Response and Prevents Duchenne Muscular Dystrophy–Associated Cardiomyopathy
por: Parvatiyar, Michelle S., et al.
Publicado: (2015) -
Mending a Broken Heart: The Role of Sarcospan in Duchenne Muscular Dystrophy–Associated Cardiomyopathy
por: Vander Heide, Richard S.
Publicado: (2015) -
Nanospan, an alternatively spliced isoform of sarcospan, localizes to the sarcoplasmic reticulum in skeletal muscle and is absent in limb girdle muscular dystrophy 2F
por: Peter, Angela K., et al.
Publicado: (2017)